Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases.

Annals of hematology - 1 Sept 2008

Rapado Inmaculada, Albizua Enriqueta, Ayala Rosa, Hernández Jose Angel, Garcia-Alonso Luis, Grande Silvia, Gallardo Miguel, Gilsanz Florinda, Martinez-Lopez Joaquin

Abstract excerpt

Several sensitive methods for the detection of JAK2 V617F mutation have been published recently, most of them based on Real Time polymerase chain reaction (PCR). However, only some of them have performed studies of diagnostic validity. This study compares three methods based on Real Time PCR to d...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Janus Kinase 2
Share to Myeloproliferative Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nucleic Acid Hybridization

Share to Polycythemia

Share to Reference Values

Share to Sensitivity and Specificity

Share to Thermodynamics

Share to Thrombocytosis

Source

Identifiers

PMID: 18575865
DOI: 10.1007/s00277-008-0512-x

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18575865-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases.PMID 18575865Read ↗

Study on the Clinical Significance of JAK2V617F Allele Burden in Philadelphia Chromosome-Negative Myeloproliferative Neoplasm.Semantic proximity Read ↗

JAK2V617F allele burden in patients with myeloproliferative neoplasms.Semantic proximity Read ↗

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera.Semantic proximity Read ↗

[A novel quantitative JAK2V617F detection kit: prospective clinical performance study comparing MPN patients and healthy subjects].Semantic proximity Read ↗

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations.Semantic proximity Read ↗

The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study.Semantic proximity Read ↗

Laboratory detection of JAK2V617F in human myeloproliferative neoplasms.Semantic proximity Read ↗

[Clinical significance of the quantification of JAK2V617F allele burden in classical Ph-negative myeloproliferative neoplasms].Semantic proximity Read ↗

[JAK2 V617F mutation burden and its clinical implications in 415 patients with myeloproliferative neoplasm].Semantic proximity Read ↗

[Usefulness of real-time semi-quantitative PCR, JAK2 MutaScreen kit for JAK2 V617F screening].Semantic proximity Read ↗

JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan.Semantic proximity Read ↗

Comparison of JAK2V617F mutation assessment employing different molecular diagnostic techniques.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.